Table of Contents 1. General Anesthetics 1.1 Inhaled Anestethics 1.2 Noninhaled Anesthetics 2. Local Anesthetics 2.1. Local Anesthetics of the Aminoether Series 2.2. Local Anesthetics of the Aminoamide Series 2.3 Topical Anesthetics 3. Analgesics 3.1 Opioid Analgesics Agonists Mixed Agonists-Antagonists Opioid Antagonists 3.2 Nonsteroid Anti-Inflammatory Drugs and Salicylic Acid Derivatives Pyrazolones p-aminophenol Derivatives Propionic Acid Derivatives Acetic Acid Derivatives Indolyl / Indeneacetic Acids Oxicames 4. Hypnotics and Sedatives 4.1 Barbiturates Long Acting Barbiturates Barbiturates of Intermediate Acting Time Short Acting Barbiturates Ultrahort Acting Barbiturates 4.2 Benzodiazepines 4.3 Other Hypnotics and Sedatives 5. Anxiolitics (Tranquilizers) 5.1. Benzodiazepines 5.2. Anxiolytics of Nonbezodiazepine Structure 6. Antipsycotics (Neuroleptics)
6.1 Phenothiazine Derivatives 6.2 Thioxantene Derivatives 6.3 Butirophenone Derivatives 6.4 Dehydroindolone Derivatives 6.5 Dibenzoxazepine and Dibenzdiazepin Derivatives 6.6 Diphenylbutilpiperidine Derivatives 6.7 Other Neuroleptics Lithium derivatives 7. Antidepressants 7.1 Tricyclic Antidepressants Secondary amines representatives of tricyclic antidepressants Teritary amines representatives of tricyclic antidepressants 7.2. Monoaminooxidase Inhibitors 7.3. Second Generation Antidepressants (atipic antidepressants) 8. Central Nervous System Stimulants 8.1. Psychomotor Stimulants 8.1.1 Methylxantines 8.1.2 Amphetamine, Methylphenidat and Pemoline 8.2 Respiration Stimulants or Analeptics 8.3 Appetite Depressants or Analeptics 9. Antiepileptics 9.1 Hydantoin Derivatives 9.2 Barbiturates 9.3 Succinimides 9.4 Valproic acid 9.5 Carbamazepine 9.6 Benzodiazepines 9.7 Acetazolamide 9.8 Oxazolimines 10. Anti-Parkinsonian Drugs 10.1 Drugs Acting on Dopaminergic Systems of Brain 10.2 Anticholinergic Drugs (Central Cholinoblockers) 11. Adrenegic (Sympatomimetic) Drugs 11.1 Direct Acting Agonists Drugs stimulating α- and β-adrenoreceptors Endogenous and synthetic catecholamines
Drugs stimulating predominantly β-adrenoreceptors Drugs stimulating predominantly α-adrenoreceptors 11.2 Non Direct Acting Agonists 11.3 Agonists of Mixed Action 12. Adrenoblocking Drugs 12.1 β-adrenoblockers 12.2 α-adrenoblockers Long Acting Nonconcurent Antagonists Nonselective, Reversible, Concurrent α 1 -Selective Adrenoblockers Ergot Alkaloids α 2 -Selective Adrenoblockers 12.3 Adrenergic Neuron Blockers 13. Cholinomimetics 13.1 Cholinomimetics of Direct Action Choline Ethers Natural Muscarine Alkaloids Natural Nicotine Alkaloids 13.2 Cholinomimeticks of Indirect Action Reversible Cholinesterase Inhibitors Carbamates Quarternary Amines Unreversible Cholinesterase Inhibitors Organophosphates Other Phosphoorganic Cholinesterase Inhibitors 14. Anticholinergic Drugs 14.1 Antimuscarinic Drugs Alkaloids Anticholinergic Quarternary Amines Anti-Parkinsonian Drugs which Tertiary Amines Tertiary Amine Midriatics 14.2 Ganglioblockers 15. Muscle Relaxants 15.1 Neuromuscular Blocking Agents Nondepolarizing Neuromuscular Blockers Depolarizing Neuromuscular Blockers 15.2 Directly Acting Muscle Relaxants 15.3 Centrally Acting Muscle Relaxants
16. Antihistamine Drugs 16.1 H 1 Antihistamine Drugs Aminoalkyl Ethers Ethylenediamines Alkylamines Piperazines Phenothiazines Piperidines 16.2 H 2 Receptor s Antagonists 17. Cardiac Glycosides and Other Inotropes 17.1 Cardiac Glycosides 17.2 Other Inotropes 18. Drugs for Tachyarrhytmias Group I Drugs Group IA Drugs Group IB Drugs Group IC Drugs Group II Drugs Group III Drugs Group IV Drugs 19. Antianginal Drugs 19.1 Nitrates and Nitrites 19.2 β-adrenoblockers 19.3 Calcium Channel Blockers 19.4 Other Drugs 20. Agents Used in Hyperlipoproteinemia 20.1 Bile Acid Sequestrans 20.2 Cholesterol Synthesis Inhibiting Agents 20.3 Other Drugs 21. Diuretics 21.1 Osmotic Diuretics 21.2 Carbonanhydraze Activity Suppressing Diuretics 21.3 Thiazide Diuretics Thiazide Diuretics Related Drugs 21.4 Loop Diuretics
21.5 Potassium Sparing Diuretics 22. Antihypertensive Drugs 22.1 Diuretics Thiazide Diuretics Thiazide Diuretics Related Drugs Potassium Sparing Diuretics 22.2 β-adrenoblockers 22.3 Centrally Acting Adrenergic Drugs (Sympatolytics) 22.4 Peripherally Acting Sympatolytics (α -Adrenoblockers ) Reversible, Concurrent α-selective adrenoblockers Adrenergic Neuron Blockers 22.5 Calcium Channel Blockers 22.6 Miotrop Hypotensive Drugs 22.7 Angiotensine Converting Enzyme Inhibitors 22.8 Calcium Channel Activators 23. Drugs for Treating of Pulmonary Diseases 23.1 Antiedema Vasoconstrictor Drugs 23.2 Anticough and Antiexpectorate Drugs Narcotic Anticough Drugs Nonnarcotic Anticough Drugs 23.3 Broncodilators (Broncholithics) Methylxantines Anticholinergics Inhibitors of Allergy Mediators Release Corticosteroids Adrenergic Drugs (Agonists of β 2 -Adrenoreceptors, Sympatomimetics) 24. Anticoagulants, Antiagregants, Trombolytics and Hemostatics 24.1 Anticoagulants Direct Acting or Parenteral Anticoagulants Non Direct Acting Anticoagulants or Enteral Anticoagulants 24.2 Antiagregants 24.3 Fibrinolytics (Trombolytics) 24.4 Hemostatics System Hemostatics Local Procoagulants 25. Thyroid and Parathyroid Drugs 25.1 Drugs for Treatment of Hypothyroidism 25.2 Drugs for Treatment of Hyperthyroidism
26. Insulin and Synthetic Hypoglycemic Agents 26.1 Insulin 26.2 Synthetic Hypoglycemic Agents 27. Corticosteroids 27.1 Glucocorticoids 27.2 Mineralocorticoids 28. Female Sex Hormones 28.1 Estrogens 28.2 Antiestrogens 28.3 Progestins 29 Male Sex Hormones and Anabolics 29.1 Androgens 29.2 Androgen Antagonists 29.3 Anabolics 30. Antineoplastic Agents 30.1 Antimetabolites 30.1.1 Folic Acid Antagonists 30.1.2 Purine Derivatives 30.1.3 Pyrimidine Derivatives 30.2 Alkylating Agents 30.2.1 Nitrogen Mustard Derivatives 30.2.2 Ethylenimine Derivatives 30.2.3 Alkylsulfonates 30.2.4 Nitrosoureas 30.2.5 Platinum Derivatives 30.3 Antibiotics Dactinomycines Bleomycines Antracyclines 30.4 Drugs Separated from Plants Alkaloids Epipodophilotoxines 30.5 Hormonal Drugs Androgens Estrogens Progestins
Corticosteroids Nonhormonal Drugs 30.6 Other Antineoplasic Drugs 31. Immunopharmacologic Drugs 31.1 Immunostimulators 31.2 Immunodepressants 32. Antibiotics 32. 1 Beta-Lactam Antibiotics 32. 1Penicillines 32. 1.2 Cefalosporines Cefalosporines of the First Generation Cefalosporines of the Second Generation Cefalosporines of the Third Generation Cefalosporines of the Fourth Generation 32.1.3 Penems and Carbapenems 32.1.4 Monobactams 32.2 Macrolid Antibiotics 32.3 Tetracyclines 32.4 Aminoglicozides 32.5 Lincosamides 32.6 Chloroamphenicol 32.7 Other Antibiotics 33. Antimicrobials 33.1 Sulfonamides and Trimetoprim Diaminopyrimidines (Trimetoprim, Pyrimethamin, Trimetoprim-Sulfa methoxazol) 33.2 Chinolones 33.3 Nitrofuranes 34. Antimicobacterials 34.1 Antituberculosis Drugs First Group Drugs Second Group Drugs 34.2 Drugs for Treatment of Leprosys 35. Antifungal Drugs 35.1 Polyene antifungal drugs 35.2 Imidazoles (tetrazoles)
35.3 Allylamines 35.4 Others 36. Antiviral Drugs 37. Antiprotozoal Drugs 37.1 Antimalarial Drugs 37.1.1 Drugs Effective on Treatment of Eritrocitar Stage of Plasmodial Infection 37.1.2 Drugs Effective on Treatment of Hepatic (Exoeritrocitar) Stage of Plasmodial Infection 8-Aminochinolines 37.1.3 Drugs Effective on Treatment of Eritrocitar and on Hepatic Stage of Plasmodial Infection 37.1.4 Other Antimalarial Drugs 37.2 Drugs Effective on Treatment of Amebiosis 37.3 Drugs Effective on Treatment of Leyshmaniosis 37.4 Drugs Effective on Treatment of Tripanosomiasis 37.5 Drugs Effective on Treatment of Other Protozoal Infections 38. Antihelmint Drugs